These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9542765)

  • 41. Bioinformatics methods for the analysis of hepatitis viruses.
    Moriconi F; Beard MR; Yuen LK
    Antivir Ther; 2013; 18(3 Pt B):531-9. PubMed ID: 23792814
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis B and C Viruses and Biologics.
    Grewal P; Sanghera R
    Skin Therapy Lett; 2017 Jul; 22(4):7-9. PubMed ID: 28732153
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expressions of inhibitory checkpoint molecules in acute and chronic HBV and HCV infections: Implications for therapeutic monitoring and personalized therapy.
    Hakim MS; Rahmadika N; Jariah ROA
    Rev Med Virol; 2020 Mar; 30(2):e2094. PubMed ID: 31825155
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Hepatitis B and C virus antiviral resistance].
    Sáez-López A; Agüero-Balbín J
    Enferm Infecc Microbiol Clin; 2006 Nov; 24(9):576-84. PubMed ID: 17125678
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Excitement grows for potential revolution in hepatitis C virus treatment.
    Opar A
    Nat Rev Drug Discov; 2010 Jul; 9(7):501-3. PubMed ID: 20592732
    [No Abstract]   [Full Text] [Related]  

  • 46. [Drugs active against hepatitis viruses].
    Goudeau A
    Rev Prat; 1997 Mar; 47(6):640-5. PubMed ID: 9183938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bio-mathematical models of viral dynamics to tailor antiviral therapy in chronic viral hepatitis.
    Brunetto MR; Colombatto P; Bonino F
    World J Gastroenterol; 2009 Feb; 15(5):531-7. PubMed ID: 19195054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Antiviral Research--16th International Congress: HBV and HCV. 27 April-1 May 2003, Savannah, GA, USA.
    Smee D
    IDrugs; 2003 Jun; 6(6):518-21. PubMed ID: 12861975
    [No Abstract]   [Full Text] [Related]  

  • 49. Natural products as promising drug candidates for the treatment of hepatitis B and C.
    Wohlfarth C; Efferth T
    Acta Pharmacol Sin; 2009 Jan; 30(1):25-30. PubMed ID: 19060918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Current status of anti-HBV chemotherapy.
    Hong JH; Choi Y; Chun BK; Lee K; Chu CK
    Arch Pharm Res; 1998 Apr; 21(2):89-105. PubMed ID: 9875415
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Worth the wait. New, more effective therapies for hepatitis C are on the way.
    Learned J
    Posit Aware; 2011; 23(1):15-8. PubMed ID: 21314021
    [No Abstract]   [Full Text] [Related]  

  • 52. Application of structural biology tools in the study of viral hepatitis and the design of antiviral therapy.
    Yao N; Hong Z; Lau JY
    Gastroenterology; 2002 Oct; 123(4):1350-63. PubMed ID: 12360496
    [No Abstract]   [Full Text] [Related]  

  • 53. Existing and future therapeutic options for hepatitis C virus infection.
    Bretner M
    Acta Biochim Pol; 2005; 52(1):57-70. PubMed ID: 15827606
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 18th International Conference on Antiviral Research. Antivirals.
    Kibble A
    IDrugs; 2005 Jun; 8(6):461-4. PubMed ID: 15906187
    [No Abstract]   [Full Text] [Related]  

  • 55. Hepatitis C therapy: other players in the game.
    Ahn J; Flamm SL
    Clin Liver Dis; 2011 Aug; 15(3):641-56. PubMed ID: 21867942
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Viral hepatitis in 2011: a major step forward.
    Marcellin P
    Liver Int; 2011 Jan; 31 Suppl 1():1-2. PubMed ID: 21205130
    [No Abstract]   [Full Text] [Related]  

  • 57. Exploitation of host clock gene machinery by hepatitis viruses B and C.
    Vinciguerra M; Mazzoccoli G; Piccoli C; Tataranni T; Andriulli A; Pazienza V
    World J Gastroenterol; 2013 Dec; 19(47):8902-9. PubMed ID: 24379614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Overcoming drug resistance in HSV, CMV, HBV and HCV infection.
    López-Labrador FX; Berenguer M; Navarro D
    Future Microbiol; 2015; 10(11):1759-66. PubMed ID: 26522939
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Advances in hepatitis B and C.
    Thomson EC; Main J
    Curr Opin Infect Dis; 2004 Oct; 17(5):449-59. PubMed ID: 15353965
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Review: Present and future directions in the treatment of chronic hepatitis B infection.
    Nicoll A; Locarnini S
    J Gastroenterol Hepatol; 1997 Dec; 12(12):843-54. PubMed ID: 9504896
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.